Email Alex Mathews

PEGylated Protein Therapeutics Market Business Opportunities and Global Industry Analysis by 2025 – Merck, Pfizer, UCB, Amgen, AstraZeneca

Higher process cost associated with PEGylation and patent expiry of certain drugs are projected to hinder the market growth.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy